WILMINGTON, MA — (Marketwired) — 04/11/13 — Implant Sciences Corporation (OTCQB: IMSC) a high technology supplier of systems and sensors for homeland security markets, will be hosting a conference call today, April 11, 2013, at 4:15 PM EDT to provide a company update to our investors.
Management will host a conference call on Thursday, April 11, 2013 at 4:15 PM Eastern time to provide an update to investors. Following the Company-s prepared remarks there will be a Q&A session. The call can be accessed by interested parties by dialing: 877-546-5020 within the U.S. or 857-244-7552 outside the U.S. and entering passcode 90133266. Participants are asked to call the assigned number approximately 5 minutes before the conference call begins. A replay of the conference call will be available approximately two hours after the call for one month by dialing: 888-286-8010 within the U.S. or 617-801-6888 outside the U.S. and entering passcode 76845591. The conference call will also be available live over the Internet at the investor relations section of Implant Sciences- website at . A replay of the webcast will be available for one month after the call.
Implant Sciences is the leader in next generation Explosives Trace Detection (ETD) technology. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosives and narcotics trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences- QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and, in addition to receiving TSA approval for air cargo screening, the Company-s QS-B220 has also received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company-s website at .
Implant Sciences Corporation Company Contact: Glenn Bolduc CEO 978-752-1700
Or
Investor Contact: Laurel Moody 646-810-0608
Only registered users can comment.
